Analysis

Imperial Brands Presses Buyback Amid Market Share Concerns

Imperial Brands purchased 190,000 shares on April 21 as part of its £1.45 billion buyback program, while its stock declined 2.29% to £27.34 following recent market share warnings. The company maintained its full-year outlook but anticipates most profit growth will occur in the second half.

Daniel Marsh · · 4 min read · 0 views
Imperial Brands Presses Buyback Amid Market Share Concerns
Mentioned in this article
BTI $55.60 +1.40%

Imperial Brands PLC continued to execute its substantial share repurchase initiative this week, acquiring 190,000 ordinary shares on April 21 for cancellation. According to regulatory filings, the tobacco giant paid an average price of 2,758.28 pence per share. This transaction represents another step in the company's £1.45 billion buyback plan announced in October, which had already seen £0.7 billion completed by March 31. Following this latest purchase, the total share count, excluding treasury shares, stands at approximately 779.1 million.

Market Reaction and Share Performance

The buyback activity coincided with continued pressure on the company's stock price. Shares of Imperial Brands fell 2.29% on Tuesday, closing at £27.34, underperforming the broader FTSE 100 index. This decline extends losses from the previous week when the company warned investors about a slight erosion of its overall market share across its five largest markets during the first half of its fiscal year. The Bristol-based manufacturer, whose portfolio includes Winston, Davidoff, and Gauloises cigarettes, now faces heightened scrutiny from investors concerned about its competitive positioning.

Financial Guidance and Profit Expectations

Despite the market share challenges, Imperial Brands has reaffirmed its full-year financial targets. The company continues to project low-single-digit revenue growth for its traditional tobacco business and anticipates double-digit percentage gains for its next-generation product portfolio, which includes vaping devices, heated tobacco units, and nicotine pouches. Management expects adjusted operating profit to increase between 3% and 5% for the full year, with free cash flow guidance remaining at a minimum of £2.2 billion after accounting for operating costs and capital expenditures.

However, the path to achieving these targets appears uneven. The company has indicated that group adjusted operating profit for the first half will show only a modest improvement compared to the prior year, with the majority of the projected growth weighted toward the second half. Furthermore, foreign exchange translation headwinds are expected to reduce first-half earnings per share by 2.0% to 2.5%.

Analyst Perspectives and Strategic Challenges

Market analysts have offered mixed assessments of the situation. Derren Nathan of Hargreaves Lansdown characterized the company's performance as a "slow but steady start," maintaining that full-year profit growth remains achievable if momentum accelerates later in the year. However, he noted that investor sentiment has been dampened by the weaker-than-expected performance in next-generation products and the market share decline.

The strategic dilemma facing Imperial Brands is pronounced. The company's largest markets—the United States, Germany, the United Kingdom, Spain, and Australia—are intensely competitive. According to recent reports, Imperial is prioritizing profitability over pure volume growth, a strategy that may involve ceding some market share while relying on price increases and stringent cost management to protect earnings. This approach contrasts with competitors like British American Tobacco and Philip Morris International, which have invested heavily in premium brands and alternative nicotine platforms. Imperial has historically competed on value, offering lower-priced alternatives in a market experiencing persistent declines in traditional cigarette demand.

AJ Bell investment director Russ Mould highlighted that CEO Lukas Paravicini is acutely aware of these challenges as he advances the company's second five-year strategic plan. Mould observed that investors have been unsettled by the market share commentary and the slower growth in next-generation categories, even with the reiterated annual guidance.

Broader Context and Future Catalysts

The ongoing share buyback provides a direct mechanism to support the stock price in the near term. Yet, significant expectations are pinned on the second half of the fiscal year. The company has cited uncertainty related to the Middle East conflict as a potential source of turbulence, though no direct business impact has been reported thus far. Additional pressures include increased promotional spending in the U.S. for its nicotine pouch business and a substantial legal settlement. Imperial made a $200 million payment to R.J. Reynolds in the first half following a Delaware Supreme Court ruling and owes another $234 million to be paid in roughly equal installments over the next three years.

Some analysts see potential value emerging from the recent stock weakness. Morningstar's Kristoffer Inton suggested the selloff has brought the shares closer to bargain territory, with the current valuation reflecting minimal growth expectations. He emphasized that the traditional tobacco business remains the primary driver of Imperial's valuation, far outweighing contributions from newer nicotine offerings. Inton's own forecast for adjusted operating profit over the next five years sits below the company's long-term target range of 3% to 5% growth.

All eyes are now on the upcoming half-year results scheduled for release on May 12, which will cover the period through March 31. Investors will closely examine pricing actions, the pace of buybacks, and cost-saving initiatives to assess whether these measures can offset concerns about lost market share. Should these efforts prove insufficient, analyst and investor scrutiny will likely intensify, with greater focus shifting to the specifics of the company's strategic roadmap for 2030.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →